Company intelligence / Profile preview

DiabetOmics

Beaverton, Oregon, United Statesdiabetomics.com ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

DiabetOmics has developed and commercialized non-invasive point-of-care diagnostic tests for early detection and monitoring of diabetes and related complications. Their products are used for conditions including preeclampsia and gestational diabetes. The company holds multiple patents in the field of biomarkers for women's health and autoimmune diseases

Therapeutic areas: Infectious DiseasesEndocrinologyImmunologyWomen's Health
Modalities: DeviceDiagnostic test
Industry: Protein Biomarker Diagnostics

Partnerships

Becton Dickinson

Beyond the preview

Go deeper on DiabetOmics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DiabetOmics.

Explore the full profile